More NewsRead More
Lexicon and Ipsen Expand Their Licensing and Commercialization Agreement for Telotristat Etiprate to Include Canada
March 18, 2015
Lexicon Pharmaceuticals Completes Enrollment In Pivotal Phase 3 Clinical Trial Of Telotristat Etiprate
March 09, 2015
Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2014 Fourth Quarter And Full Year Financial Results
March 04, 2015
Lexicon To Report Fourth Quarter And Year End 2014 Financial Results On March 4, 2015
March 02, 2015
Lexicon To Present At The Cowen 35th Annual Health Care Conference
February 26, 2015
Expert Briefing on Biotech Stocks - Lexicon Pharma, Sunesis Pharma, Navidea Biopharma, Tekmira Pharma, and Intrexon
February 19, 2015
Lexicon To Present At The BIO CEO & Investor Conference
February 06, 2015
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here